Anjana Unnikrishnan, Anusha Ashokan, Meera Menon, 
Keralam

Researchers of Cusat granted patent for cancer immunotherapy

The patent was facilitated by the IPR facilitation cell at Inter University Centre for IPR Studies (IUCIPRS), Cusat.

Express News Service

KOCHI: A team of researchers from the Department of Biotechnology at Cochin University of Science and Technology (Cusat) has been granted a patent for a significant innovation in the field of cancer immunotherapy.

The team, comprising Dr Anusha Ashokan, former DST Inspire faculty, Meera Menon, senior research fellow, and Anjana Unnikrishnan, former project trainee, developed a novel adjuvant formulation based on aluminium-incorporated polymer nanoparticles.

The adjuvant, designed to enhance the efficacy of cancer vaccines, has been demonstrated to reduce tumour growth and improve anti-tumour immune response in mouse cancer model (melanoma). By improving the efficacy of cancer vaccines, it could offer a safer and more effective alternative to traditional cancer treatments.

The patent was facilitated by the IPR facilitation cell at Inter University Centre for IPR Studies (IUCIPRS), Cusat.

Cauvery water dispute: SC rejects TN's plea for release of 11 TMC water by Karnataka

Cyclone Akvan landfall process begins, over 3 lakh people evacuated in Odisha

Jaiswal, Rahul put India in command after Nicholls' 175 powers NZ to 368

Tamil Nadu: Police raid four locations linked to ex-minister P Moorthy in illegal quarrying cases

SC asks poll panel for more SIR data, says it can only bar fraudulent BLAs